Compare Novartis with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs ELDER PHARMA - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS ELDER PHARMA NOVARTIS/
ELDER PHARMA
 
P/E (TTM) x 517.1 -0.2 - View Chart
P/BV x 29.0 0.1 28,720.1% View Chart
Dividend Yield % 1.5 0.0 -  

Financials

 NOVARTIS   ELDER PHARMA
EQUITY SHARE DATA
    NOVARTIS
Mar-19
ELDER PHARMA
Jun-14
NOVARTIS/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs980380 257.9%   
Low Rs600188 319.3%   
Sales per share (Unadj.) Rs198.7491.2 40.5%  
Earnings per share (Unadj.) Rs21.0-3.2 -659.0%  
Cash flow per share (Unadj.) Rs22.314.4 154.5%  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs307.5376.5 81.7%  
Shares outstanding (eoy) m24.6920.54 120.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.00.6 687.6%   
Avg P/E ratio x37.7-89.3 -42.2%  
P/CF ratio (eoy) x35.519.7 180.1%  
Price / Book Value ratio x2.60.8 340.7%  
Dividend payout %47.70-   
Avg Mkt Cap Rs m19,5085,833 334.4%   
No. of employees `0000.6NA-   
Total wages/salary Rs m1,1712,179 53.7%   
Avg. sales/employee Rs Th8,445.4NM-  
Avg. wages/employee Rs Th2,015.7NM-  
Avg. net profit/employee Rs Th891.0NM-  
INCOME DATA
Net Sales Rs m4,90710,089 48.6%  
Other income Rs m783257 305.0%   
Total revenues Rs m5,68910,346 55.0%   
Gross profit Rs m123-792 -15.5%  
Depreciation Rs m32361 8.8%   
Interest Rs m162,756 0.6%   
Profit before tax Rs m858-3,653 -23.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m340125 271.7%   
Profit after tax Rs m518-65 -792.2%  
Gross profit margin %2.5-7.8 -31.9%  
Effective tax rate %39.6-3.4 -1,157.0%   
Net profit margin %10.6-0.6 -1,628.9%  
BALANCE SHEET DATA
Current assets Rs m8,0559,240 87.2%   
Current liabilities Rs m1,8509,998 18.5%   
Net working cap to sales %126.4-7.5 -1,683.7%  
Current ratio x4.40.9 471.1%  
Inventory Days Days4546 97.2%  
Debtors Days Days3460 56.6%  
Net fixed assets Rs m15010,124 1.5%   
Share capital Rs m123206 60.0%   
"Free" reserves Rs m7,4695,582 133.8%   
Net worth Rs m7,5927,734 98.2%   
Long term debt Rs m04,889 0.0%   
Total assets Rs m9,82422,882 42.9%  
Interest coverage x54.9-0.3 -16,890.5%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.50.4 113.3%   
Return on assets %5.411.8 46.2%  
Return on equity %6.8-0.8 -807.0%  
Return on capital %11.522.3 51.6%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m58307 18.8%   
Fx outflow Rs m1,326125 1,058.5%   
Net fx Rs m-1,269181 -699.8%   
CASH FLOW
From Operations Rs m-1,94311,754 -16.5%  
From Investments Rs m2,742-561 -489.3%  
From Financial Activity Rs m-298-6,762 4.4%  
Net Cashflow Rs m5014,432 11.3%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 7.5 26.7%  
FIIs % 1.6 16.8 9.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 36.1 59.6%  
Shareholders   41,647 16,479 252.7%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   TORRENT PHARMA  ALKEM LABORATORIES  AJANTA PHARMA  PFIZER  ALEMBIC PHARMA  

Compare NOVARTIS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 205 Points Lower; Power and Realty Stocks Witness Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day on a negative note.

Related Views on News

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (2QFY19); Net Profit Down 64.1% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, NOVARTIS has posted a net profit of Rs 94 m (down 64.1% YoY). Sales on the other hand came in at Rs 1 bn (down 36.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY19); Net Profit Up 42.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, NOVARTIS has posted a net profit of Rs 100 m (up 42.2% YoY). Sales on the other hand came in at Rs 1 bn (up 20.3% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth?(The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Your Safe Income Options for 2020(Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jan 21, 2020 03:35 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS